Unnamed: 0,Drug,Recommendation,Rationale,Creatinine Clearance,Condition,ExStandardized
0,Brompheniramine,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,BROMPHENIRAMINE
1,Carbinoxamine,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,CARBINOXAMINE
2,Chlorpheniramine,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,CHLORPHENIRAMINE
3,Clemastine,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,CLEMASTINE
4,Cyproheptadine,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,CYPROHEPTADINE
5,Dexbrompheniramine,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,DEXBROMPHENIRAMINE
6,Dexchlorpheniramine,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,CHLORPHENIRAMINE
7,Dimenhydrinate,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,DIMENHYDRINATE
8,Diphenhydramine (oral),Avoid. Use of diphenhydramine in situations such as acute treatment of severe allergic reaction may be appropriate,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,DIPHENHYDRAMINE
9,Doxylamine,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,DOXYLAMINE
10,Hydroxyzine,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,HYDROXYZINE
11,Meclizine,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,MECLIZINE
12,Promethazine,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,PROMETHAZINE
13,Pyrilamine,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,MEPYRAMINE
14,Triprolidine,Avoid,"Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",,,TRIPROLIDINE
15,Benztropine (oral),Avoid,Not recommended for prevention or treatment of extrapyramidal symptoms with antipsychotics; more effective agents available for treatment of Parkinson disease,,,BENZATROPINE
16,Trihexyphenidyl,Avoid,Not recommended for prevention or treatment of extrapyramidal symptoms with antipsychotics; more effective agents available for treatment of Parkinson disease,,,TRIHEXYPHENIDYL
17,Atropine (excludes ophthalmic),Avoid,"Highly anticholinergic, uncertain effectivenes",,,ATROPINE
18,Belladonna alkaloids,Avoid,"Highly anticholinergic, uncertain effectivenes",,,BELLADONNA ALKALOIDS
19,Ipratropium,Avoid,"Highly anticholinergic, uncertain effectivenes",,,IPRATROPIUM BROMIDE
20,Hyoscyamine,Avoid,"Highly anticholinergic, uncertain effectivenes",,,HYOSCYAMINE
21,Scopolamine,Avoid,"Highly anticholinergic, uncertain effectivenes",,,SCOPOLAMINE
22,Hyoscine,Avoid,"Highly anticholinergic, uncertain effectivenes",,,SCOPOLAMINE
23,Fentonium,Avoid,"Highly anticholinergic, uncertain effectivenes",,,FENTONIUM
24,Methylatropine,Avoid,"Highly anticholinergic, uncertain effectivenes",,,HOMATROPINE METHYLBROMIDE
25,Butropium,Avoid,"Highly anticholinergic, uncertain effectivenes",,,BUTROPIUM
26,Clidinium/Chlordiazepoxide,Avoid,"Highly anticholinergic, uncertain effectivenes",,,CHLORDIAZEPOXIDE/CLIDINIUM
27,Dicyclomine/Homatropine (excludes opthalmic),Avoid,"Highly anticholinergic, uncertain effectivenes",,,DICYCLOMINE/HOMATROPINE
28,Methscopolamine,Avoid,"Highly anticholinergic, uncertain effectivenes",,,METHYLSCOPOLAMINE
29,Propantheline,Avoid,"Highly anticholinergic, uncertain effectivenes",,,PROPANTHELINE
30,"Dipyridamole, oral short acting",Avoid. Does not apply to the extended-release combination with aspirin,May cause orthostatic hypotension; more effective alternatives available; IV form acceptable for use in cardiac stress testing,,,DIPYRIDAMOLE
31,Nitrofurantoin ,Avoid if creatinine clearance <30mL/min or for long-term suppression,"Potential for pulmonary toxicity, hepatoxicity, and peripheral neuropathy, especially with long-term use; safer alternatives available",,,NITROFURANTOIN
32,Doxazosin,Avoid if used to treat high blood pressure,"High risk of orthostatic hypotension and associated harms, especially in older adults; not recommended as routine treatment for hypertension; alternative agents have superior risk/benefit profile",,,DOXAZOSIN
33,Prazosin,Avoid if used to treat high blood pressure,"High risk of orthostatic hypotension and associated harms, especially in older adults; not recommended as routine treatment for hypertension; alternative agents have superior risk/benefit profile",,,PRAZOSIN
34,Terazosin,Avoid if used to treat high blood pressure,"High risk of orthostatic hypotension and associated harms, especially in older adults; not recommended as routine treatment for hypertension; alternative agents have superior risk/benefit profile",,,TERAZOSIN
35,Clonidine,Avoid as a first-line treatment for high blood pressure,High risk of adverse CNS effects; may cause bradycardia and orthostatic hypotension; not recommended as routine treatment for hypertension,,,CLONIDINE
36,Guanabenz,Avoid,High risk of adverse CNS effects; may cause bradycardia and orthostatic hypotension; not recommended as routine treatment for hypertension,,,GUANABENZ
37,Guanfacine,Avoid,High risk of adverse CNS effects; may cause bradycardia and orthostatic hypotension; not recommended as routine treatment for hypertension,,,GUANFACINE
38,Methyldopa,Avoid,High risk of adverse CNS effects; may cause bradycardia and orthostatic hypotension; not recommended as routine treatment for hypertension,,,METHYLDOPA
39,Reserpine (>0.1 mg/day),Avoid,High risk of adverse CNS effects; may cause bradycardia and orthostatic hypotension; not recommended as routine treatment for hypertension,,,RESERPINE
40,Disopyramide,Avoid,May induce heart failure in older adults because of potent negative inotropic action; strongly anticholinergic; other antiarrhythmic drugs preferred,,,DISOPYRAMIDE
41,Dronedarone,Avoid if diagnosed with atrial fibrillation or severe or recently decompensated heart failure,Worse outcomes have been reported in patients taking dronedarone who have permanent atrial fibrillation or severe or recently decompensated heart failure,,,DRONEDARONE
42,Digoxin,"Avoid as a first-line treatment for atrial fibrillation or heart failure. If used as treatment for atrial fibrillation or heart failure, avoid dosages >0.125 mg/day","Use in atrial fibrillation: should not be used as a first-line agent in atrial fibrillation, because there are safer and more effective alternatives for rate control supported by
high-quality evidence
Use in heart failure: evidence for benefits and harms of digoxin is conflicting and of lower quality; most but not all of the evidence concerns use in HFrEF. There is strong evidence for other agents as first-line therapy to reduce hospitalizations and mortality in adults with HFrEF. In heart failure, higher dosages are not associated with additional benefit and may increase risk of toxicity. Decreased renal clearance of digoxin may lead to increased risk of toxic effects; further dose reduction may be necessary in those with stage 4 or 5 chronic kidney disease",,,DIGOXIN
43,Nifedipine (immediate release),Avoid,Potential for hypotension; risk of precipitating myocardial ischemia,,,NIFEDIPINE
44,Amiodarone,Avoid as first-line therapy for atrial fibrillation unless diagnosed with heart failure or substantial left ventricular hypertrophy,Effective for maintaining sinus rhythm but has greater toxicities than other antiarrhythmics used in atrial fibrillation; may be reasonable first-line therapy in patients with concomitant heart failure or substantial left ventricular hypertrophy if rhythm control is preferred over rate control,,,AMIODARONE
45,Amitriptyline,Avoid,"Highly anticholinergic, sedating, and cause orthostatic hypotension",,,AMITRIPTYLINE
46,Amoxapine,Avoid,"Highly anticholinergic, sedating, and cause orthostatic hypotension",,,AMOXAPINE
47,Clomipramine,Avoid,"Highly anticholinergic, sedating, and cause orthostatic hypotension",,,CLOMIPRAMINE
48,Desipramine,Avoid,"Highly anticholinergic, sedating, and cause orthostatic hypotension",,,DESIPRAMINE
49,Doxepin (>6 mg/day),Avoid,"Highly anticholinergic, sedating, and cause orthostatic hypotension; safety profile of low-dose doxepin (≤6 mg/day) comparable to that of placebo",,,DOXEPIN
50,Imipramine,Avoid,"Highly anticholinergic, sedating, and cause orthostatic hypotension",,,IMIPRAMINE
51,Nortriptyline,Avoid,"Highly anticholinergic, sedating, and cause orthostatic hypotension",,,NORTRIPTYLINE
52,Paroxetine,Avoid,"Highly anticholinergic, sedating, and cause orthostatic hypotension",,,PAROXETINE
53,Protriptyline,Avoid,"Highly anticholinergic, sedating, and cause orthostatic hypotension",,,PROTRIPTYLINE
54,Trimipramine,Avoid,"Highly anticholinergic, sedating, and cause orthostatic hypotension",,,TRIMIPRAMINE
55,Chlorpromazine,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,CHLORPROMAZINE
56,Droperidol,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,DROPERIDOL
57,Fluphenazine,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,FLUPHENAZINE
58,Haloperidol,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,HALOPERIDOL
59,Loxapine,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,LOXAPINE
60,Perphenazine,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,PERPHENAZINE
61,Pimozide,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,PIMOZIDE
62,Prochlorperazine,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,PROCHLORPERAZINE
63,Thioridazine,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,THIORIDAZINE
64,Thiothixene,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,THIOTHIXENE
65,Trifluoperazine,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,TRIFLUOPERAZINE
66,Aripiprazole,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,ARIPIPRAZOLE
67,Asenapine,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,ASENAPINE
68,Clozapine,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,CLOZAPINE
69,Iloperidone,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,ILOPERIDONE
70,Lurasidone,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,LURASIDONE
71,Olanzapine,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,OLANZAPINE
72,Paliperidone,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,PALIPERIDONE
73,Quetiapine,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,QUETIAPINE
74,Risperidone,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,RISPERIDONE
75,Ziprasidone,"Avoid unless used for schizophrenia, bipolar disorder, or as a short-term antiemetic during chemotherapy","Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",,,ZIPRASIDONE
76,Amobarbital,Avoid,"High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",,,AMOBARBITAL
77,Butabarbital,Avoid,"High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",,,BUTABARBITAL
78,Butalbital,Avoid,"High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",,,BUTALBITAL
79,Mephobarbital,Avoid,"High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",,,METHYLPHENOBARBITAL
80,Pentobarbital,Avoid,"High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",,,PENTOBARBITAL
81,Phenobarbital,Avoid,"High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",,,PHENOBARBITAL
82,Secobarbital,Avoid,"High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",,,SECOBARBITAL
83,Alprazolam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,ALPRAZOLAM
84,Estazolam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,ESTAZOLAM
85,Lorazepam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,LORAZEPAM
86,Oxazepam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,OXAZEPAM
87,Temazepam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,TEMAZEPAM
88,Triazolam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,TRIAZOLAM
89,Chlordiazepoxide,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,CHLORDIAZEPOXIDE
90,Clonazepam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,CLONAZEPAM
91,Clorazepate,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,CLORAZEPATE
92,Diazepam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,DIAZEPAM
93,Flurazepam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,FLURAZEPAM
94,Quazepam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,QUAZEPAM
95,Meprobamate,Avoid,High rate of physical dependence; sedating,,,MEPROBAMATE
96,Bromazepam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,BROMAZEPAM
97,Clobazam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,CLOBAZAM
98,Nitrazepam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,NITRAZEPAM
99,Clonazepam,Avoid,"Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults
May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",,,CLONAZEPAM
100,Eszopiclone,Avoid,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics have adverse events similar to those of benzodiazepines in older adults (eg, delirium, falls, fractures); increased emergency room visits/hospitalizations; motor vehicle crashes; minimal improvement in sleep latency and duration",,,ESZOPICLONE
101,Zaleplon,Avoid,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics have adverse events similar to those of benzodiazepines in older adults (eg, delirium, falls, fractures); increased emergency room visits/hospitalizations; motor vehicle crashes; minimal improvement in sleep latency and duration",,,ZALEPLON
102,Zolpidem,Avoid,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics have adverse events similar to those of benzodiazepines in older adults (eg, delirium, falls, fractures); increased emergency room visits/hospitalizations; motor vehicle crashes; minimal improvement in sleep latency and duration",,,ZOLPIDEM
103,Ergoloid mesylates,Avoid,Lack of efficacy,,,ERGOLOID MESYLATE
104,Isoxsuprine,Avoid,Lack of efficacy,,,ISOXSUPRINE
105,Methyltestosterone,Avoid unless diagnosed with hypogonadism with clinical symptoms,Potential for cardiac problems; contraindicated in men with prostate cancer,,,METHYLTESTOSTERONE
106,Testosterone,Avoid unless diagnosed with hypogonadism with clinical symptoms,Potential for cardiac problems; contraindicated in men with prostate cancer,,,TESTOSTERONE
107,Desiccated thyroid ,Avoid,Concerns about cardiac effects; safer alternatives available,,,DESICCATED THYROID
108,Estradiol/Levonorgestrel,Avoid,"Evidence of carcinogenic potential (breast and endometrium); lack of cardioprotective effect and cognitive protection in older women.
Evidence indicates that vaginal estrogens for the treatment of vaginal dryness are safe and effective; women with a history of breast cancer who do not respond to nonhormonal therapies are advised to discuss the risks and benefits of low-dose vaginal estrogen (dosages of estradiol <25 μg twice weekly) with their healthcare provider",,,ESTRADIOL/LEVONORGESTREL
109,Estradiol/Northindrone Acetate,Avoid,"Evidence of carcinogenic potential (breast and endometrium); lack of cardioprotective effect and cognitive protection in older women.
Evidence indicates that vaginal estrogens for the treatment of vaginal dryness are safe and effective; women with a history of breast cancer who do not respond to nonhormonal therapies are advised to discuss the risks and benefits of low-dose vaginal estrogen (dosages of estradiol <25 μg twice weekly) with their healthcare provider",,,ESTRADIOL/NORETHINDRONE ACETATE
110,Estradiol/Drospirenone,Avoid,"Evidence of carcinogenic potential (breast and endometrium); lack of cardioprotective effect and cognitive protection in older women.
Evidence indicates that vaginal estrogens for the treatment of vaginal dryness are safe and effective; women with a history of breast cancer who do not respond to nonhormonal therapies are advised to discuss the risks and benefits of low-dose vaginal estrogen (dosages of estradiol <25 μg twice weekly) with their healthcare provider",,,DROSPIRENONE/ESTRADIOL
111,Ospemifene,Avoid,"Evidence of carcinogenic potential (breast and endometrium); lack of cardioprotective effect and cognitive protection in older women.
Evidence indicates that vaginal estrogens for the treatment of vaginal dryness are safe and effective; women with a history of breast cancer who do not respond to nonhormonal therapies are advised to discuss the risks and benefits of low-dose vaginal estrogen (dosages of estradiol <25 μg twice weekly) with their healthcare provider",,,OSPEMIFENE
112,Estradiol/Norgestimate,Avoid,"Evidence of carcinogenic potential (breast and endometrium); lack of cardioprotective effect and cognitive protection in older women.
Evidence indicates that vaginal estrogens for the treatment of vaginal dryness are safe and effective; women with a history of breast cancer who do not respond to nonhormonal therapies are advised to discuss the risks and benefits of low-dose vaginal estrogen (dosages of estradiol <25 μg twice weekly) with their healthcare provider",,,ESTRADIOL/NORGESTIMATE
113,Estrogen/Medroxyprogesterone,Avoid,"Evidence of carcinogenic potential (breast and endometrium); lack of cardioprotective effect and cognitive protection in older women.
Evidence indicates that vaginal estrogens for the treatment of vaginal dryness are safe and effective; women with a history of breast cancer who do not respond to nonhormonal therapies are advised to discuss the risks and benefits of low-dose vaginal estrogen (dosages of estradiol <25 μg twice weekly) with their healthcare provider",,,ESTROGENS/MEDROXYPROGESTERONE
114,Estropipate,Avoid unless using intravaginally,"Evidence of carcinogenic potential (breast and endometrium); lack of cardioprotective effect and cognitive protection in older women.
Evidence indicates that vaginal estrogens for the treatment of vaginal dryness are safe and effective; women with a history of breast cancer who do not respond to nonhormonal therapies are advised to discuss the risks and benefits of low-dose vaginal estrogen (dosages of estradiol <25 μg twice weekly) with their healthcare provider",,,ESTROPIPATE
115,Estrogen,Avoid unless using intravaginally,"Evidence of carcinogenic potential (breast and endometrium); lack of cardioprotective effect and cognitive protection in older women.
Evidence indicates that vaginal estrogens for the treatment of vaginal dryness are safe and effective; women with a history of breast cancer who do not respond to nonhormonal therapies are advised to discuss the risks and benefits of low-dose vaginal estrogen (dosages of estradiol <25 μg twice weekly) with their healthcare provider",,,CONJUGATED ESTROGENS
116,Estradiol,Avoid unless using intravaginally,"Evidence of carcinogenic potential (breast and endometrium); lack of cardioprotective effect and cognitive protection in older women.
Evidence indicates that vaginal estrogens for the treatment of vaginal dryness are safe and effective; women with a history of breast cancer who do not respond to nonhormonal therapies are advised to discuss the risks and benefits of low-dose vaginal estrogen (dosages of estradiol <25 μg twice weekly) with their healthcare provider",,,ESTRADIOL
117,Growth Hormone,Avoid unless diagnosed with growth hormone deficiency due to established etiology,"Impact on body composition is small and associated with edema, arthralgia, carpal tunnel syndrome, gynecomastia, impaired fasting glucose",,,PEGVISOMANT
118,Insulin Lispro,Avoid unless using with concurrent long-acting insulin,"Higher risk of hypoglycemia without improvement in hyperglycemia management regardless of care setting
Avoid insulin regimens that include only short- or rapid-acting insulin dosed according to current blood glucose levels without concurrent use of basal or long-acting insulin. This recommendation does not apply to regimens that contain basal insulin or long-acting insulin",,,INSULIN LISPRO
119,Insulin,Avoid unless using with concurrent long-acting insulin,"Higher risk of hypoglycemia without improvement in hyperglycemia management regardless of care setting
Avoid insulin regimens that include only short- or rapid-acting insulin dosed according to current blood glucose levels without concurrent use of basal or long-acting insulin. This recommendation does not apply to regimens that contain basal insulin or long-acting insulin",,,INULIN
120,Insulin Aspart,Avoid unless using with concurrent long-acting insulin,"Higher risk of hypoglycemia without improvement in hyperglycemia management regardless of care setting
Avoid insulin regimens that include only short- or rapid-acting insulin dosed according to current blood glucose levels without concurrent use of basal or long-acting insulin. This recommendation does not apply to regimens that contain basal insulin or long-acting insulin",,,INSULIN ASPART
121,Insulin Glulisine,Avoid unless using with concurrent long-acting insulin,"Higher risk of hypoglycemia without improvement in hyperglycemia management regardless of care setting
Avoid insulin regimens that include only short- or rapid-acting insulin dosed according to current blood glucose levels without concurrent use of basal or long-acting insulin. This recommendation does not apply to regimens that contain basal insulin or long-acting insulin",,,INSULIN GLULISINE
122,Megestrol ,Avoid,Minimal effect on weight; increases risk of thrombotic events and possibly death in older adults,,,MEGESTROL
123,Chlorpropamide,Avoid,Prolonged half-life in older adults; can cause prolonged hypoglycemia; causes SIADH,,,CHLORPROPAMIDE
124,Glimepiride,Avoid,Higher risk of severe prolonged hypoglycemia in older adults,,,GLIMEPIRIDE
125,Glibenclamide,Avoid,Higher risk of severe prolonged hypoglycemia in older adults,,,GLYBURIDE
126,Glyburide,Avoid,Higher risk of severe prolonged hypoglycemia in older adults,,,GLYBURIDE
127,Metoclopramide,Avoid unless used for gastroparesis (use not to exceed 12 weeks),"Can cause extrapyramidal effects, including tardive dyskinesia; risk may be greater in frail older adults and with prolonged exposure",,,METOCLOPRAMIDE
128,Mineral oil (oral),Avoid,Potential for aspiration and adverse effects; safer alternatives available,,,MINERAL OIL
129,Omeprazole,"Avoid scheduled use for >8 weeks unless for high-risk patients (eg, oral corticosteroids or chronic NSAID use), erosive esophagitis, Barrett esophagitis, pathological hypersecretory condition, or demonstrated need for maintenance treatment (eg, because of failure of drug discontinuation trial or H2-receptor antagonists)",Risk of Clostridium difficile infection and bone loss and fractures,,,OMEPRAZOLE
130,Lansoprazole,"Avoid scheduled use for >8 weeks unless for high-risk patients (eg, oral corticosteroids or chronic NSAID use), erosive esophagitis, Barrett esophagitis, pathological hypersecretory condition, or demonstrated need for maintenance treatment (eg, because of failure of drug discontinuation trial or H2-receptor antagonists)",Risk of Clostridium difficile infection and bone loss and fractures,,,LANSOPRAZOLE
131,Pantoprazole,"Avoid scheduled use for >8 weeks unless for high-risk patients (eg, oral corticosteroids or chronic NSAID use), erosive esophagitis, Barrett esophagitis, pathological hypersecretory condition, or demonstrated need for maintenance treatment (eg, because of failure of drug discontinuation trial or H2-receptor antagonists)",Risk of Clostridium difficile infection and bone loss and fractures,,,PANTOPRAZOLE
132,Rabeprazole,"Avoid scheduled use for >8 weeks unless for high-risk patients (eg, oral corticosteroids or chronic NSAID use), erosive esophagitis, Barrett esophagitis, pathological hypersecretory condition, or demonstrated need for maintenance treatment (eg, because of failure of drug discontinuation trial or H2-receptor antagonists)",Risk of Clostridium difficile infection and bone loss and fractures,,,RABEPRAZOLE
133,Esomeprazole,"Avoid scheduled use for >8 weeks unless for high-risk patients (eg, oral corticosteroids or chronic NSAID use), erosive esophagitis, Barrett esophagitis, pathological hypersecretory condition, or demonstrated need for maintenance treatment (eg, because of failure of drug discontinuation trial or H2-receptor antagonists)",Risk of Clostridium difficile infection and bone loss and fractures,,,ESOMEPRAZOLE
134,Dexlansoprazole,"Avoid scheduled use for >8 weeks unless for high-risk patients (eg, oral corticosteroids or chronic NSAID use), erosive esophagitis, Barrett esophagitis, pathological hypersecretory condition, or demonstrated need for maintenance treatment (eg, because of failure of drug discontinuation trial or H2-receptor antagonists)",Risk of Clostridium difficile infection and bone loss and fractures,,,LANSOPRAZOLE
135,Meperidine,Avoid,"Oral analgesic not effective in dosages commonly used; may have higher risk of neurotoxicity, including delirium, than other opioids; safer alternatives available",,,MEPERIDINE
136,Aspirin (>325 mg/day),"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,ACETYLSALICYLIC ACID
137,Diclofenac,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,DICLOFENAC
138,Diflunisal,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,DIFLUNISAL
139,Etodolac,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,ETODOLAC
140,Fenoprofen,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,FENOPROFEN
141,Ibuprofen,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,IBUPROFEN
142,Ketoprofen,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,KETOPROFEN
143,Meclofenamate,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,MECLOFENAMIC ACID
144,Mefenamic Acid,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,MEFENAMIC ACID
145,Meloxicam,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,MELOXICAM
146,Nabumetone,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,NABUMETONE
147,Naproxen,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,NAPROXEN
148,Oxaprozin,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,OXAPROZIN
149,Piroxicam,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,PIROXICAM
150,Sulindac,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,SULINDAC
151,Tolmetin,"Avoid chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)","Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by NSAIDs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related",,,TOLMETIN
152,Indomethacin,Avoid,"Increased risk of gastrointestinal bleeding/peptic ulcer disease and acute kidney injury in older adults. Indomethacin is more likely than other NSAIDs to have adverse CNS effects. Of all the NSAIDs, indomethacin has the most adverse effects",,,INDOMETHACIN
153,Ketorolac,Avoid,Increased risk of gastrointestinal bleeding/peptic ulcer disease and acute kidney injury in older adults,,,KETOROLAC
154,Carisoprodol,Avoid,"Most muscle relaxants poorly tolerated by older adults because some have anticholinergic adverse effects, sedation, increased risk of fractures; effectiveness at dosages tolerated by older adults questionable",,,CARISOPRODOL
155,Chlorzoxazone,Avoid,"Most muscle relaxants poorly tolerated by older adults because some have anticholinergic adverse effects, sedation, increased risk of fractures; effectiveness at dosages tolerated by older adults questionable",,,CHLORZOXAZONE
156,Cyclobenzaprine,Avoid,"Most muscle relaxants poorly tolerated by older adults because some have anticholinergic adverse effects, sedation, increased risk of fractures; effectiveness at dosages tolerated by older adults questionable",,,CYCLOBENZAPRINE
157,Metaxalone,Avoid,"Most muscle relaxants poorly tolerated by older adults because some have anticholinergic adverse effects, sedation, increased risk of fractures; effectiveness at dosages tolerated by older adults questionable",,,METAXALONE
158,Methocarbamol,Avoid,"Most muscle relaxants poorly tolerated by older adults because some have anticholinergic adverse effects, sedation, increased risk of fractures; effectiveness at dosages tolerated by older adults questionable",,,METHOCARBAMOL
159,Orphenadrine,Avoid,"Most muscle relaxants poorly tolerated by older adults because some have anticholinergic adverse effects, sedation, increased risk of fractures; effectiveness at dosages tolerated by older adults questionable",,,ORPHENADRINE
160,Desmopressin ,Avoid as treatment of nocturia or nocturnal polyuria,High risk of hyponatremia; safer alternative treatments,,,DESMOPRESSIN
161,Aspirin (for primary prevention of cardiovascular disease and colorectal cancer),Use with caution in adults ≥70 years,"Risk of major bleeding from aspirin increases markedly in older age. Several studies suggest lack of net benefit when used for primary prevention in older adult with cardiovascular risk factors, but evidence is not conclusive. Aspirin is generally indicated for secondary prevention in older adults with established cardiovascular disease",,,ACETYLSALICYLIC ACID
162,Dabigatran,Use with caution for treatment of VTE or atrial fibrillation in adults ≥75 years,Increased risk of gastrointestinal bleeding compared with warfarin and reported rates with other direct oral anticoagulants when used for long-term treatment of VTE or atrial fibrillation in adults ≥75 years,,,DABIGATRAN ETEXILATE
163,Rivaroxaban,Use with caution in adults ≥75 years,Increased risk of gastrointestinal bleeding compared with warfarin and reported rates with other direct oral anticoagulants when used for long-term treatment of VTE or atrial fibrillation in adults ≥75 years,,,RIVAROXABAN
164,Prasugrel,Use with caution,"Increased risk of bleeding in older adults; benefit in highest-risk older adults (eg, those with prior myocardial infarction or diabetes mellitus) may offset risk when used for its approved indication of acute coronary syndrome to be managed with percutaneous coronary intervention",,,PRASUGREL
165,Chlorpromazine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,CHLORPROMAZINE
166,Droperidol,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,DROPERIDOL
167,Fluphenazine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,FLUPHENAZINE
168,Haloperidol,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,HALOPERIDOL
169,Loxapine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,LOXAPINE
170,Perphenazine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,PERPHENAZINE
171,Pimozide,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,PIMOZIDE
172,Prochlorperazine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,PROCHLORPERAZINE
173,Thioridazine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,THIORIDAZINE
174,Thiothixene,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,THIOTHIXENE
175,Trifluoperazine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,TRIFLUOPERAZINE
176,Aripiprazole,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,ARIPIPRAZOLE
177,Asenapine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,ASENAPINE
178,Clozapine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,CLOZAPINE
179,Iloperidone,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,ILOPERIDONE
180,Lurasidone,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,LURASIDONE
181,Olanzapine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,OLANZAPINE
182,Paliperidone,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,PALIPERIDONE
183,Quetiapine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,QUETIAPINE
184,Risperidone,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,RISPERIDONE
185,Ziprasidone,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,ZIPRASIDONE
186,Pimavanserin,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,PIMAVANSERIN
187,Carbamazepine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,CARBAMAZEPINE
188,Chlorothiazide,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,CHLOROTHIAZIDE
189,Chlorthalidone,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,CHLORTHALIDONE
190,Indapamide,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,INDAPAMIDE
191,Hydrochlorothiazide,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,HYDROCHLOROTHIAZIDE
192,Methyclothiazide,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,METHYCLOTHIAZIDE
193,Metolazone,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,METOLAZONE
194,Bumetanide,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,BUMETANIDE
195,Furosemide,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,FUROSEMIDE
196,Ethacrynate,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,ETHACRYNIC ACID
197,Torsemide,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,TORASEMIDE
198,Amiloride Hydrochloride,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,AMILORIDE
199,Spironolactone,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,SPIRONOLACTONE
200,Triamterene,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,TRIAMTERENE
201,Acetazolamide,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,ACETAZOLAMIDE
202,Methazolamide,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,METHAZOLAMIDE
203,Mirtazapine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,MIRTAZAPINE
204,Oxcarbazepine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,OXCARBAZEPINE
205,Amitriptyline,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,AMITRIPTYLINE
206,Amoxapine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,AMOXAPINE
207,Clomipramine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,CLOMIPRAMINE
208,Desipramine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,DESIPRAMINE
209,Doxepin,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,DOXEPIN
210,Imipramine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,IMIPRAMINE
211,Nortriptyline,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,NORTRIPTYLINE
212,Paroxetine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,PAROXETINE
213,Protriptyline,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,PROTRIPTYLINE
214,Trimipramine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,TRIMIPRAMINE
215,Citalopram,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,CITALOPRAM
216,Escitalopram,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,ESCITALOPRAM
217,Fluoxetine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,FLUOXETINE
218,Paroxetine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,PAROXETINE
219,Sertraline,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,SERTRALINE
220,Desvenlafaxine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,DESVENLAFAXINE
221,Duloxetine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,DULOXETINE
222,Levomilnacipran,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,LEVOMILNACIPRAN
223,Milnacipran,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,MILNACIPRAN
224,Venlafaxine,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,VENLAFAXINE
225,Tramadol,Use with caution,May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults,,,TRAMADOL
226,Dextromethorphan/Quinidine,Use with caution,Limited efficacy in patients with behavioral symptoms of dementia (does not apply to treatment of PBA). May increase risk of falls and concerns with clinically significant drug interactions. Does not apply to treatment of pseudobulbar affect,,,DEXTROMETHORPHAN/QUINIDINE
227,Trimethoprim/Sulfamethoxazole,Use with caution in patients on ACEI or ARB and decreased creatinine clearance,Increased risk of hyperkalemia when used concurrently with an ACEI or ARB in presence of decreased creatinine clearance,,,SULFAMETHOXAZOLE/TRIMETHOPRIM
228,Ciprofloxacin,Doses used to treat common infections typically require reduction when CrCl <30 mL/min,"Increased risk of CNS effects (eg, seizures, confusion) and tendon rupture",<30,,CIPROFLOXACIN
229,Trimethoprim/Sulfamethoxazole,"Reduce dose if CrCl 15-29 mL/min
Avoid if CrCl <15 mL/min",Increased risk of worsening of renal function and hyperkalemia,<30,,SULFAMETHOXAZOLE/TRIMETHOPRIM
230,Amiloride,Avoid,Increased potassium and decreased sodium,<30,,AMILORIDE
231,Apixaban,Avoid,Lack of evidence for efficacy and safety in patients with a CrCl <25 mL/min,<25,,APIXABAN
232,Dabigatran,Avoid; dose adjustment advised when CrCl >30 mL/min in the presence of drug-drug interactions,Lack of evidence for efficacy and safety in individuals with a CrCl <30 mL/min. Label dose for patients with a CrCl 15-30 mL/min based on pharmacokinetic data,<30,,DABIGATRAN ETEXILATE
233,Dofetilide,"Reduce dose if CrCl 20-59 mL/min
Avoid if CrCl <20 mL/min",QTc prolongation and torsade de pointes,<60,,DOFETILIDE
234,Edoxaban,Avoid,Lack of evidence of efficacy or safety in patients with a CrCl <30 mL/min,"<15, >95",,EDOXABAN
235,Edoxaban,Reduce dose,Lack of evidence of efficacy or safety in patients with a CrCl <30 mL/min,15-50,,EDOXABAN
236,Enoxaparin,Reduce dose,Increased risk of bleeding,<30,,ENOXAPARIN
237,Fondaparinux,Avoid,Increased risk of bleeding,<30,,FONDAPARINUX SODIUM
238,Rivaroxaban,"Nonvalvular atrial fibrillation: reduce dose if CrCl 15-50 mL/min; avoid if CrCl <15 mL/min
Venous thromboembolism treatment and for VTE prophylaxis with hip or knee replacement: avoid if CrCl <30 mL/min",Lack of efficacy or safety evidence in patients with a CrCl <30 mL/min,<50,,RIVAROXABAN
239,Spironolactone,Avoid,Increased potassium,<30,,SPIRONOLACTONE
240,Triamterene,Avoid,Increased potassium and decreased sodium,<30,,TRIAMTERENE
241,Duloxetine,Avoid,"Increased gastrointestinal adverse effects (nausea, diarrhea)",<30,,DULOXETINE
242,Gabapentin,Reduce dose,CNS adverse effects,<60,,GABAPENTIN
243,Levetiracetam,Reduce dose,CNS adverse effects,<=80,,LEVETIRACETAM
244,Pregabalin,Reduce dose,CNS adverse effects,<60,,PREGABALIN
245,Tramadol,"Immediate release: reduce dose
Extended release: avoid",CNS adverse effects,<30,,TRAMADOL
246,Cimetidine,Reduce dose,Mental status changes,<50,,CIMETIDINE
247,Famotidine,Reduce dose,Mental status changes,<50,,FAMOTIDINE
248,Nizatidine,Reduce dose,Mental status changes,<50,,NIZATIDINE
249,Ranitidine,Reduce dose,Mental status changes,<50,,RANITIDINE
250,Colchicine,Reduce dose; monitor for adverse effects,"Gastrointestinal, neuromuscular, bone marrow toxicity",<30,,COLCHICINE
251,Probenecid,Avoid,Loss of effectiveness,<30,,PROBENECID
252,Cilostazol,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,CILOSTAZOL
253,Aspirin,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,ACETYLSALICYLIC ACID
254,Diclofenac,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,DICLOFENAC
255,Diflunisal,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,DIFLUNISAL
256,Etodolac,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,ETODOLAC
257,Fenoprofen,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,FENOPROFEN
258,Ibuprofen,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,IBUPROFEN
259,Ketoprofen,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,KETOPROFEN
260,Meclofenamate,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,MECLOFENAMIC ACID
261,Mefenamic Acid,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,MEFENAMIC ACID
262,Meloxicam,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,MELOXICAM
263,Nabumetone,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,NABUMETONE
264,Naproxen,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,NAPROXEN
265,Oxaprozin,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,OXAPROZIN
266,Piroxicam,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,PIROXICAM
267,Sulindac,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,SULINDAC
268,Tolmetin,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,TOLMETIN
269,Celecoxib,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with preserved ejection fraction,CELECOXIB
270,Cilostazol,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,CILOSTAZOL
271,Diltiazem,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,DILTIAZEM
272,Verapamil,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,VERAPAMIL
273,Aspirin,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,ACETYLSALICYLIC ACID
274,Diclofenac,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,DICLOFENAC
275,Diflunisal,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,DIFLUNISAL
276,Etodolac,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,ETODOLAC
277,Fenoprofen,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,FENOPROFEN
278,Ibuprofen,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,IBUPROFEN
279,Ketoprofen,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,KETOPROFEN
280,Meclofenamate,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,MECLOFENAMIC ACID
281,Mefenamic Acid,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,MEFENAMIC ACID
282,Meloxicam,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,MELOXICAM
283,Nabumetone,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,NABUMETONE
284,Naproxen,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,NAPROXEN
285,Oxaprozin,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,OXAPROZIN
286,Piroxicam,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,PIROXICAM
287,Sulindac,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,SULINDAC
288,Tolmetin,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,TOLMETIN
289,Celecoxib,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",,Heart failure with reduced ejection fraction,CELECOXIB
290,Pioglitazone,Use with caution,Potential to promote fluid retention and/or exacerbate heart failure,,"Heart failure with reduced ejection fraction, asymptomatic",PIOGLITAZONE
291,Rosiglitazone,Use with caution,Potential to promote fluid retention and/or exacerbate heart failure,,"Heart failure with reduced ejection fraction, asymptomatic",ROSIGLITAZONE
292,Dronedarone,Use with caution,Potential to promote fluid retention and/or exacerbate heart failure,,"Heart failure with reduced ejection fraction, asymptomatic",DRONEDARONE
293,Pioglitazone,Use with caution,Potential to promote fluid retention and/or exacerbate heart failure,,"Heart failure with preserved ejection fraction, asymptomatic",PIOGLITAZONE
294,Rosiglitazone,Use with caution,Potential to promote fluid retention and/or exacerbate heart failure,,"Heart failure with preserved ejection fraction, asymptomatic",ROSIGLITAZONE
295,Dronedarone,Use with caution,Potential to promote fluid retention and/or exacerbate heart failure,,"Heart failure with preserved ejection fraction, asymptomatic",DRONEDARONE
296,Donepezil,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,DONEPEZIL
297,Rivastigmine,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,RIVASTIGMINE
298,Galantamine,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,GALANTAMINE
299,Tacrine,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,TACRINE
300,Doxazosin,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,DOXAZOSIN
301,Prazosin,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,PRAZOSIN
302,Terazosin,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,TERAZOSIN
303,Amitriptyline,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,AMITRIPTYLINE
304,Imipramine,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,IMIPRAMINE
305,Clomipramine,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,CLOMIPRAMINE
306,Trimipramine,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,TRIMIPRAMINE
307,Doxepin,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,DOXEPIN
308,Chlorpromazine,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,CHLORPROMAZINE
309,Thioridazine,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,THIORIDAZINE
310,Olanzapine,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia,,Syncope,OLANZAPINE
311,Disopyramide,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,DISOPYRAMIDE
312,Pyrilamine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,MEPYRAMINE
313,Triprolidine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,TRIPROLIDINE
314,Amitriptyline,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,AMITRIPTYLINE
315,Amoxapine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,AMOXAPINE
316,Clomipramine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CLOMIPRAMINE
317,Desipramine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,DESIPRAMINE
318,Doxepin (>6 mg),Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,DOXEPIN
319,Darifenacin,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,DARIFENACIN
320,Imipramine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,IMIPRAMINE
321,Fesoterodine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,FESOTERODINE
322,Nortriptyline,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,NORTRIPTYLINE
323,Flavoxate,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,FLAVOXATE
324,Paroxetine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,PAROXETINE
325,Oxybutynin,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,OXYBUTYNIN
326,Protriptyline,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,PROTRIPTYLINE
327,Solifenacin,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,SOLIFENACIN
328,Trimipramine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,TRIMIPRAMINE
329,Tolterodine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,TOLTERODINE
330,Trospium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,TROSPIUM
331,Prochlorperazine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,PROCHLORPERAZINE
332,Promethazine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,PROMETHAZINE
333,Benztropine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,BENZATROPINE
334,Trihexyphenidyl,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,TRIHEXYPHENIDYL
335,Brompheniramine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,BROMPHENIRAMINE
336,Carbinoxamine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CARBINOXAMINE
337,Chlorpromazine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CHLORPROMAZINE
338,Chlorpheniramine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CHLORPHENIRAMINE
339,Clozapine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CLOZAPINE
340,Clemastine/Loxapine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CLEMASTINE/LOXAPINE
341,Cyproheptadine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CYPROHEPTADINE
342,Olanzapine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,OLANZAPINE
343,Dexbrompheniramine/Perphenazine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,DEXBROMPHENIRAMINE/PERPHENAZINE
344,Dexchlorpheniramine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CHLORPHENIRAMINE
345,Thioridazine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,THIORIDAZINE
346,Dimenhydrinate,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,DIMENHYDRINATE
347,Trifluoperazine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,TRIFLUOPERAZINE
348,Diphenhydramine (oral),Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,DIPHENHYDRAMINE
349,Doxylamine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,DOXYLAMINE
350,Hydroxyzine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,HYDROXYZINE
351,Atropine (excludes ophthalmic),Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,ATROPINE
352,Meclizine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,MECLIZINE
353,Belladonna alkaloids,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,BELLADONNA ALKALOIDS
354,Clidinium/Chlordiazepoxide,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CHLORDIAZEPOXIDE/CLIDINIUM
355,Scopolamine (excludes ophthalmic),Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,SCOPOLAMINE
356,Dicyclomine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,DICYCLOMINE
357,Homatropine (excludes ophthalmic),Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,HOMATROPINE
358,Hyoscyamine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,HYOSCYAMINE
359,Cyclobenzaprine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CYCLOBENZAPRINE
360,Methscopolamine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,METHYLSCOPOLAMINE
361,Orphenadrine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,ORPHENADRINE
362,Propantheline,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,PROPANTHELINE
363,Alprazolam,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,ALPRAZOLAM
364,Estazolam,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,ESTAZOLAM
365,Lorazepam,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,LORAZEPAM
366,Oxazepam,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,OXAZEPAM
367,Temazepam,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,TEMAZEPAM
368,Triazolam,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,TRIAZOLAM
369,Chlordiazepoxide,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CHLORDIAZEPOXIDE
370,Clonazepam,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CLONAZEPAM
371,Clorazepate,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CLORAZEPATE
372,Diazepam,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,DIAZEPAM
373,Flurazepam,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,FLURAZEPAM
374,Quazepam,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,QUAZEPAM
375,Chlorpromazine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CHLORPROMAZINE
376,Droperidol,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,DROPERIDOL
377,Fluphenazine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,FLUPHENAZINE
378,Haloperidol,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,HALOPERIDOL
379,Loxapine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,LOXAPINE
380,Perphenazine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,PERPHENAZINE
381,Pimozide,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,PIMOZIDE
382,Prochlorperazine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,PROCHLORPERAZINE
383,Thioridazine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,THIORIDAZINE
384,Thiothixene,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,THIOTHIXENE
385,Trifluoperazine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,TRIFLUOPERAZINE
386,Aripiprazole,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,ARIPIPRAZOLE
387,Asenapine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,ASENAPINE
388,Clozapine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CLOZAPINE
389,Iloperidone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,ILOPERIDONE
390,Lurasidone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,LURASIDONE
391,Olanzapine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,OLANZAPINE
392,Paliperidone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,PALIPERIDONE
393,Quetiapine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,QUETIAPINE
394,Risperidone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,RISPERIDONE
395,Ziprasidone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,ZIPRASIDONE
396,Pimavanserin,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,PIMAVANSERIN
397,Hydrocortisone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,HYDROCORTISONE
398,Cortisone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,DEXAMETHASONE
399,Betamethasone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,BETAMETHASONE
400,Prednisone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,PREDNISONE
401,Prenisolone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,PREDNISOLONE
402,Triamcinolone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,TRIAMCINOLONE
403,Methylprednisolone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,METHYLPREDNISOLONE
404,Dexamethasone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,DEXAMETHASONE
405,Ethamethasoneb,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,BETAMETHASONE
406,Cimetidine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,CIMETIDINE
407,Famotidine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,FAMOTIDINE
408,Nizatidine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,NIZATIDINE
409,Ranitidine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,RANITIDINE
410,Meperidine,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,MEPERIDINE
411,Eszopiclone,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,ESZOPICLONE
412,Zaleplon,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,ZALEPLON
413,Zolpidem,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Delirium,ZOLPIDEM
414,Disopyramide,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,DISOPYRAMIDE
415,Pyrilamine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,MEPYRAMINE
416,Triprolidine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,TRIPROLIDINE
417,Amitriptyline,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,AMITRIPTYLINE
418,Amoxapine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,AMOXAPINE
419,Clomipramine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CLOMIPRAMINE
420,Desipramine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,DESIPRAMINE
421,Doxepin (>6 mg),Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,DOXEPIN
422,Darifenacin,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,DARIFENACIN
423,Imipramine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,IMIPRAMINE
424,Fesoterodine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,FESOTERODINE
425,Nortriptyline,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,NORTRIPTYLINE
426,Flavoxate,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,FLAVOXATE
427,Paroxetine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,PAROXETINE
428,Oxybutynin,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,OXYBUTYNIN
429,Protriptyline,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,PROTRIPTYLINE
430,Solifenacin,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,SOLIFENACIN
431,Trimipramine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,TRIMIPRAMINE
432,Tolterodine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,TOLTERODINE
433,Trospium,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,TROSPIUM
434,Prochlorperazine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,PROCHLORPERAZINE
435,Promethazine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,PROMETHAZINE
436,Benztropine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,BENZATROPINE
437,Trihexyphenidyl,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,TRIHEXYPHENIDYL
438,Brompheniramine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,BROMPHENIRAMINE
439,Carbinoxamine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CARBINOXAMINE
440,Chlorpromazine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CHLORPROMAZINE
441,Chlorpheniramine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CHLORPHENIRAMINE
442,Clozapine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CLOZAPINE
443,Clemastine/Loxapine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CLEMASTINE/LOXAPINE
444,Cyproheptadine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CYPROHEPTADINE
445,Olanzapine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,OLANZAPINE
446,Dexbrompheniramine/Perphenazine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,DEXBROMPHENIRAMINE/PERPHENAZINE
447,Dexchlorpheniramine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CHLORPHENIRAMINE
448,Thioridazine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,THIORIDAZINE
449,Dimenhydrinate,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,DIMENHYDRINATE
450,Trifluoperazine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,TRIFLUOPERAZINE
451,Diphenhydramine (oral),Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,DIPHENHYDRAMINE
452,Doxylamine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,DOXYLAMINE
453,Hydroxyzine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,HYDROXYZINE
454,Atropine (excludes ophthalmic),Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,ATROPINE
455,Meclizine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,MECLIZINE
456,Belladonna alkaloids,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,BELLADONNA ALKALOIDS
457,Clidinium/Chlordiazepoxide,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CHLORDIAZEPOXIDE/CLIDINIUM
458,Scopolamine (excludes ophthalmic),Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,SCOPOLAMINE
459,Dicyclomine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,DICYCLOMINE
460,Homatropine (excludes ophthalmic),Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,HOMATROPINE
461,Hyoscyamine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,HYOSCYAMINE
462,Cyclobenzaprine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CYCLOBENZAPRINE
463,Methscopolamine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,METHYLSCOPOLAMINE
464,Orphenadrine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,ORPHENADRINE
465,Propantheline,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,PROPANTHELINE
466,Alprazolam,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,ALPRAZOLAM
467,Estazolam,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,ESTAZOLAM
468,Lorazepam,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,LORAZEPAM
469,Oxazepam,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,OXAZEPAM
470,Temazepam,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,TEMAZEPAM
471,Triazolam,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,TRIAZOLAM
472,Chlordiazepoxide,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CHLORDIAZEPOXIDE
473,Clonazepam,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CLONAZEPAM
474,Clorazepate,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CLORAZEPATE
475,Diazepam,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,DIAZEPAM
476,Flurazepam,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,FLURAZEPAM
477,Quazepam,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,QUAZEPAM
478,Eszopiclone,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,ESZOPICLONE
479,Zaleplon,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,ZALEPLON
480,Zolpidem,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,ZOLPIDEM
481,Chlorpromazine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CHLORPROMAZINE
482,Droperidol,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,DROPERIDOL
483,Fluphenazine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,FLUPHENAZINE
484,Haloperidol,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,HALOPERIDOL
485,Loxapine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,LOXAPINE
486,Perphenazine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,PERPHENAZINE
487,Pimozide,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,PIMOZIDE
488,Prochlorperazine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,PROCHLORPERAZINE
489,Thioridazine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,THIORIDAZINE
490,Thiothixene,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,THIOTHIXENE
491,Trifluoperazine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,TRIFLUOPERAZINE
492,Aripiprazole,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,ARIPIPRAZOLE
493,Asenapine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,ASENAPINE
494,Clozapine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,CLOZAPINE
495,Iloperidone,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,ILOPERIDONE
496,Lurasidone,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,LURASIDONE
497,Olanzapine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,OLANZAPINE
498,Paliperidone,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,PALIPERIDONE
499,Quetiapine,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,QUETIAPINE
500,Risperidone,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,RISPERIDONE
501,Ziprasidone,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,ZIPRASIDONE
502,Pimavanserin,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia.",,Dementia or cognitive impairment,PIMAVANSERIN
503,Phenytoin,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,PHENYTOIN
504,Valproic Acid,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,VALPROIC ACID
505,Phenobarbital,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,PHENOBARBITAL
506,Lamotrigine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,LAMOTRIGINE
507,Carbamazepine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,CARBAMAZEPINE
508,Topiramate,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,TOPIRAMATE
509,Oxcarbazepine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,OXCARBAZEPINE
510,Zonisamide,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,ZONISAMIDE
511,Gabapentin,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,GABAPENTIN
512,Levetiracetam,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,LEVETIRACETAM
513,Pregabalin,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,PREGABALIN
514,Clonazepam,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,CLONAZEPAM
515,Lacosamide,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,LACOSAMIDE
516,Rufinamide,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,RUFINAMIDE
517,Vigabatrin,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,VIGABATRIN
518,Chlorpromazine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,CHLORPROMAZINE
519,Droperidol,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,DROPERIDOL
520,Fluphenazine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,FLUPHENAZINE
521,Haloperidol,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,HALOPERIDOL
522,Loxapine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,LOXAPINE
523,Perphenazine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,PERPHENAZINE
524,Pimozide,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,PIMOZIDE
525,Prochlorperazine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,PROCHLORPERAZINE
526,Thioridazine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,THIORIDAZINE
527,Thiothixene,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,THIOTHIXENE
528,Trifluoperazine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,TRIFLUOPERAZINE
529,Aripiprazole,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,ARIPIPRAZOLE
530,Asenapine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,ASENAPINE
531,Clozapine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,CLOZAPINE
532,Iloperidone,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,ILOPERIDONE
533,Lurasidone,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,LURASIDONE
534,Olanzapine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,OLANZAPINE
535,Paliperidone,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,PALIPERIDONE
536,Quetiapine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,QUETIAPINE
537,Risperidone,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,RISPERIDONE
538,Ziprasidone,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,ZIPRASIDONE
539,Pimavanserin,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,PIMAVANSERIN
540,Alprazolam,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,ALPRAZOLAM
541,Estazolam,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,ESTAZOLAM
542,Lorazepam,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,LORAZEPAM
543,Oxazepam,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,OXAZEPAM
544,Temazepam,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,TEMAZEPAM
545,Triazolam,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,TRIAZOLAM
546,Chlordiazepoxide,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,CHLORDIAZEPOXIDE
547,Clonazepam,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,CLONAZEPAM
548,Clorazepate,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,CLORAZEPATE
549,Diazepam,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,DIAZEPAM
550,Flurazepam,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,FLURAZEPAM
551,Quazepam,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,QUAZEPAM
552,Eszopiclone,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,ESZOPICLONE
553,Zaleplon,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,ZALEPLON
554,Zolpidem,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,ZOLPIDEM
555,Amitriptyline,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,AMITRIPTYLINE
556,Amoxapine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,AMOXAPINE
557,Clomipramine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,CLOMIPRAMINE
558,Desipramine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,DESIPRAMINE
559,Doxepin,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,DOXEPIN
560,Imipramine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,IMIPRAMINE
561,Nortriptyline,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,NORTRIPTYLINE
562,Paroxetine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,PAROXETINE
563,Protriptyline,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,PROTRIPTYLINE
564,Trimipramine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,TRIMIPRAMINE
565,Citalopram,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,CITALOPRAM
566,Escitalopram,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,ESCITALOPRAM
567,Fluoxetine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,FLUOXETINE
568,Paroxetine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,PAROXETINE
569,Sertraline,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,SERTRALINE
570,Desvenlafaxine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,DESVENLAFAXINE
571,Duloxetine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,DULOXETINE
572,Levomilnacipran,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,LEVOMILNACIPRAN
573,Milnacipran,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,MILNACIPRAN
574,Venlafaxine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,VENLAFAXINE
575,Opium,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,OPIUM
576,Heroin,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,HEROIN
577,Codeine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,CODEINE
578,Oxycodone,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,OXYCODONE
579,Hydrocodone,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,HYDROCODONE
580,Tramadol,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,TRAMADOL
581,Morphine,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,MORPHINE
582,Hydromorphone,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,HYDROMORPHONE
583,Fentanyl,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,FENTANYL
584,Carfentanil,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",,History of falls or fractures,ALFENTANIL
585,Metoclopramide,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,METOCLOPRAMIDE
586,Prochlorperazine,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,PROCHLORPERAZINE
587,Promethazine,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,PROMETHAZINE
588,Chlorpromazine,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,CHLORPROMAZINE
589,Droperidol,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,DROPERIDOL
590,Fluphenazine,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,FLUPHENAZINE
591,Haloperidol,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,HALOPERIDOL
592,Loxapine,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,LOXAPINE
593,Perphenazine,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,PERPHENAZINE
594,Pimozide,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,PIMOZIDE
595,Prochlorperazine,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,PROCHLORPERAZINE
596,Thioridazine,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,THIORIDAZINE
597,Thiothixene,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,THIOTHIXENE
598,Trifluoperazine,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,TRIFLUOPERAZINE
599,Aripiprazole,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,ARIPIPRAZOLE
600,Asenapine,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,ASENAPINE
601,Iloperidone,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,ILOPERIDONE
602,Lurasidone,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,LURASIDONE
603,Olanzapine,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,OLANZAPINE
604,Paliperidone,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,PALIPERIDONE
605,Risperidone,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,RISPERIDONE
606,Ziprasidone,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others.",,Parkinson Disease,ZIPRASIDONE
607,Aspirin (>325 mg/day),Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,ACETYLSALICYLIC ACID
608,Diclofenac,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,DICLOFENAC
609,Diflunisal,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,DIFLUNISAL
610,Etodolac,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,ETODOLAC
611,Fenoprofen,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,FENOPROFEN
612,Ibuprofen,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,IBUPROFEN
613,Ketoprofen,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,KETOPROFEN
614,Meclofenamate,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,MECLOFENAMIC ACID
615,Mefenamic acid,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,MEFENAMIC ACID
616,Meloxicam,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,MELOXICAM
617,Nabumetone,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,NABUMETONE
618,Naproxen,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,NAPROXEN
619,Oxaprozin,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,OXAPROZIN
620,Piroxicam,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,PIROXICAM
621,Sulindac,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,SULINDAC
622,Tolmetin,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers,,History of gastric or duodenal ulcers,TOLMETIN
623,Aspirin,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),ACETYLSALICYLIC ACID
624,Diclofenac,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),DICLOFENAC
625,Diflunisal,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),DIFLUNISAL
626,Etodolac,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),ETODOLAC
627,Fenoprofen,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),FENOPROFEN
628,Ibuprofen,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),IBUPROFEN
629,Ketoprofen,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),KETOPROFEN
630,Meclofenamate,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),MECLOFENAMIC ACID
631,Mefenamic acid,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),MEFENAMIC ACID
632,Meloxicam,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),MELOXICAM
633,Nabumetone,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),NABUMETONE
634,Naproxen,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),NAPROXEN
635,Oxaprozin,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),OXAPROZIN
636,Piroxicam,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),PIROXICAM
637,Sulindac,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),SULINDAC
638,Tolmetin,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),TOLMETIN
639,Celecoxib,Avoid,May increase risk of acute kidney injury and further decline of renal function,,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),CELECOXIB
640,Estradiol/Levonorgestrel,Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),,Urinary incontinence (women),ESTRADIOL/LEVONORGESTREL
641,Estradiol/Northindrone,Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),,Urinary incontinence (women),ESTRADIOL/NORETHINDRONE
642,Estradiol/Drospirenone,Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),,Urinary incontinence (women),DROSPIRENONE/ESTRADIOL
643,Ospemifene,Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),,Urinary incontinence (women),OSPEMIFENE
644,Estradiol/Norgestimate,Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),,Urinary incontinence (women),ESTRADIOL/NORGESTIMATE
645,Estrogen/Medroxyprogesterone,Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),,Urinary incontinence (women),ESTROGENS/MEDROXYPROGESTERONE
646,Estropipate,Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),,Urinary incontinence (women),ESTROPIPATE
647,Estrogen,Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),,Urinary incontinence (women),CONJUGATED ESTROGENS
648,Estradiol,Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),,Urinary incontinence (women),ESTRADIOL
649,Doxazosin,Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),,Urinary incontinence (women),DOXAZOSIN
650,Prazosin,Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),,Urinary incontinence (women),PRAZOSIN
651,Terazosin,Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers),,Urinary incontinence (women),TERAZOSIN
652,Disopyramide,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),DISOPYRAMIDE
653,Pyrilamine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),MEPYRAMINE
654,Triprolidine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),TRIPROLIDINE
655,Amitriptyline,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),AMITRIPTYLINE
656,Amoxapine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),AMOXAPINE
657,Clomipramine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),CLOMIPRAMINE
658,Desipramine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),DESIPRAMINE
659,Doxepin (>6 mg),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),DOXEPIN
660,Darifenacin,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),DARIFENACIN
661,Imipramine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),IMIPRAMINE
662,Fesoterodine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),FESOTERODINE
663,Nortriptyline,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),NORTRIPTYLINE
664,Flavoxate,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),FLAVOXATE
665,Paroxetine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),PAROXETINE
666,Oxybutynin,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),OXYBUTYNIN
667,Protriptyline,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),PROTRIPTYLINE
668,Solifenacin,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),SOLIFENACIN
669,Trimipramine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),TRIMIPRAMINE
670,Tolterodine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),TOLTERODINE
671,Trospium,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),TROSPIUM
672,Prochlorperazine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),PROCHLORPERAZINE
673,Promethazine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),PROMETHAZINE
674,Benztropine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),BENZATROPINE
675,Trihexyphenidyl,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),TRIHEXYPHENIDYL
676,Brompheniramine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),BROMPHENIRAMINE
677,Carbinoxamine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),CARBINOXAMINE
678,Chlorpromazine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),CHLORPROMAZINE
679,Chlorpheniramine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),CHLORPHENIRAMINE
680,Clozapine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),CLOZAPINE
681,Clemastine/Loxapine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),CLEMASTINE/LOXAPINE
682,Cyproheptadine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),CYPROHEPTADINE
683,Olanzapine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),OLANZAPINE
684,Dexbrompheniramine/Perphenazine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),DEXBROMPHENIRAMINE/PERPHENAZINE
685,Dexchlorpheniramine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),CHLORPHENIRAMINE
686,Thioridazine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),THIORIDAZINE
687,Dimenhydrinate,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),DIMENHYDRINATE
688,Trifluoperazine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),TRIFLUOPERAZINE
689,Diphenhydramine (oral),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),DIPHENHYDRAMINE
690,Doxylamine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),DOXYLAMINE
691,Hydroxyzine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),HYDROXYZINE
692,Atropine (excludes ophthalmic),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),ATROPINE
693,Meclizine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),MECLIZINE
694,Belladonna alkaloids,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),BELLADONNA ALKALOIDS
695,Clidinium/Chlordiazepoxide,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),CHLORDIAZEPOXIDE/CLIDINIUM
696,Scopolamine (excludes ophthalmic),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),SCOPOLAMINE
697,Dicyclomine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),DICYCLOMINE
698,Homatropine (excludes ophthalmic),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),HOMATROPINE
699,Hyoscyamine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),HYOSCYAMINE
700,Cyclobenzaprine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),CYCLOBENZAPRINE
701,Methscopolamine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),METHYLSCOPOLAMINE
702,Orphenadrine,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),ORPHENADRINE
703,Propantheline,Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention,,Benign prostatic hyperplasia (BPH),PROPANTHELINE
